secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-05-22T20:05:31+00:00
Accession:  0001213900-26-060556
Event type: other
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical receives Nasdaq extension to November 16, 2026 to cure bid price deficiency
--------------------------------------------------------------------------------

- Company received Nasdaq notice granting additional 180-day period until November 16, 2026 to meet $1.00 minimum bid price.
- Initial compliance period ended May 18, 2026; company had not yet satisfied the bid price requirement.
- Extension based on meeting other listing requirements and written intent to cure via reverse stock split if needed.
- If not cured by new deadline, common stock may be delisted from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/ea0292043-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-060556

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer